Fortress Biotech, Inc. (FBIO) Stock Overview
NASDAQ · Healthcare · Biotechnology
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Fortress Biotech, Inc.
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the…
Source: Yahoo Finance
Sector & Industry
Fortress Biotech, Inc. operates in the Healthcare sector, within the Biotechnology industry group. It is listed on the NASDAQ exchange.
Fortress Biotech, Inc. at a Glance
| Company | Fortress Biotech, Inc. |
| Ticker | FBIO |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $2.72 |
| Market cap | $90.71M |
| P/E ratio (trailing) | 0.98 |
| EPS (trailing) | $2.77 |
| 52-week high | $4.53 |
| 52-week low | $2.18 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 1.19 |
| Return on equity (ROE) | 115.98% |
| Debt-to-equity | 25.87% |
| Average volume | 595,276 |
| Shares outstanding | 33.35M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 78 |
| Country | United States |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Frequently Asked Questions
- What is Fortress Biotech, Inc.'s current P/E ratio?
- Fortress Biotech, Inc. (FBIO) has a trailing P/E ratio of 0.98 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Fortress Biotech, Inc.'s market capitalisation?
- Fortress Biotech, Inc.'s market cap is $90.71M based on our latest snapshot. See how it ranks by market cap →
- What is FBIO's 52-week range?
- Over the past 52 weeks, FBIO has traded between $2.18 and $4.53. What does the 52-week range mean? →
- How volatile is Fortress Biotech, Inc. compared to the market?
- Fortress Biotech, Inc. has a beta of 1.19, meaning it has historically moved more than the broader market. What does beta measure? →
- Does Fortress Biotech, Inc. pay a dividend?
- Fortress Biotech, Inc. does not currently pay a dividend according to our latest data.
- What exchange is FBIO listed on?
- FBIO is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Fortress Biotech, Inc. in?
- Fortress Biotech, Inc. is classified in the Healthcare sector. Compare with Healthcare peers →
For compound interest, percentage change and other investing maths, try our free online calculators.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →